Israel's Lead COVID-19 Vaccine Candide Progresses to Phase 2 Study

Hadassah-University Medical Center and Sheba Medical Center reported that they had completed administering the BriLife coronavirus vaccine candidate to 80 volunteers, thus completing the Phase I clinical trial, reported JPost on November 27, 2020.

“We are pleased to announce that the first phase of the clinical research trial of the coronavirus vaccine was a success,” said the director of the clinical research unit at Hadassah, Prof. Yossi Karko.